MEI Pharma, Inc. — Form D
MEI Pharma, Inc. of SAN DIEGO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2018-05-30. The offering totals $75.0M, of which $75.0M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2018-05-30
- Form: D
- Accession: 0001262104-18-000002
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $75.0M
- Amount sold: $75.0M
- Investors: 20
- Date of first sale: 2018-05-15
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-313534
Issuer
- Name: MEI Pharma, Inc.
- CIK: 0001262104
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 3611 Valley Centre Drive, SAN DIEGO, CA, 92130
- Phone: 858-369-7100
Officers, directors & promoters (15)
| Name | Role | Location |
|---|
| Charles V Baltic III | Director | San Diego, CA |
| Kevan E Clemens | Director | San Diego, CA |
| Frederick W Driscoll | Director | Florham Park, NJ |
| Nicholas R Glover | Director | San Diego, CA |
| Daniel P Gold | Director | San Diego, CA |
| Thomas C Reynolds | Director | San Diego, CA |
| William D Rueckert | Director | New York, NY |
| Christine A White | Director | San Diego, CA |
| Brian G Drazba | Executive Officer | San Diego, CA |
| Daniel P Gold | Executive Officer | San Diego, CA |
| Robert D Mass | Executive Officer | San Diego, CA |
| David M Urso | Executive Officer | San Diego, CA |
| Thomas M Zech | Executive Officer | San Diego, CA |
| Bryan M Williams | Director | San Diego, CA |
| Leah D Cann | Director | San Diego, CA |
Other filings by this issuer (1)
More